KR880006196A - 알레르기 및 염증 치료제인 디하이드로피리딘 - Google Patents
알레르기 및 염증 치료제인 디하이드로피리딘 Download PDFInfo
- Publication number
- KR880006196A KR880006196A KR870012409A KR870012409A KR880006196A KR 880006196 A KR880006196 A KR 880006196A KR 870012409 A KR870012409 A KR 870012409A KR 870012409 A KR870012409 A KR 870012409A KR 880006196 A KR880006196 A KR 880006196A
- Authority
- KR
- South Korea
- Prior art keywords
- compound
- alkyl
- methyl
- formula
- chlorophenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
Abstract
내용 없음
Description
본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음
Claims (12)
- 일반식(I)의 화합물 또는 약제학적으로 허용되는 그의 염.상기 식에서, R은 페닐이거나 니트로, 할로, C1-C4알콕시, 아릴(C1-C4알콕시), C1-C4알킬티오, C1-C4알킬 설포닐, 하이드록시, 트리플루오로메틸 및 시아노로부터 선택된 하나 또는 그 이상의 치환체에 의해 치환된 페닐이고;R1및 R2는 각각 독립적으로 수소 또는 C1-C4알킬이거나, 또는 두 그룹은 그들이 결합되어 있는 질소 원자와 함께 결합하여 필로리디닐, 피페리디노, 모르폴리노, 피페라지닐, N-(C1-C4알킬)피페라지닐 또는 N-(C2-C4알카노일) 피페라지닐 그룹을 형성할 수 있거나;또는 R2는 수소 또는 C1-C4알킬이고, R1은 CN,C3-C7사이클로알킬, 아릴, 헤테로아릴, 또는 C3-C7사이클로알킬, C1-C4알콕시카보닐, 아릴 및 헤테로아릴로부터 선택된 하나 또는 그 이상의 치환체에 의해 치환된 C1-C4알킬 그룹이고; R3는 OH,C1-C6알킬옥시, 아릴(C1-C4알콕시) 또는 NR4R5(여기에서, R4및 R5는 각각 독립적으로 수소 또는 C1-C6알킬이거나, 또는 두 그룹은 그들이 결합되어 있는 질소 원자와 함께 결합하여 피롤리딜, 피페리디노, 모르폴리노, 피페라지닐 또는 N-(C1-C4알킬) 피페라지닐 그룹을 형성할 수 이다)이고;Y는 X를 산소 원자에 결합시키는 쇄중에 적어도 2개의 탄소워자를 갖는 직쇄 또는 측쇄일 수 있는 탄소수 2내지 8의 알킬렌 그룹이고;X는 C1-C4알킬, C1-C4알콕시, 할로, CF3및 CN으로부터 선택된 하나 또는 그 이상의 치환체로 임의 치환된 벤즈이미다졸-1-일 또느 벤즈이미다졸-2-일이다.
- 제1항에 있어서, R이 2-클로로페닐인 화합물.
- 제2항에 있어서, R3가 에톡시 또는 이소프로폭시인 화합물.
- 제1항에 있어서, Y가 -(CH2)2-이고 X가 2-메틸벤즈이미다졸-1-일인 화합물.
- 제1항에 있어서, Y가 -(CH2)3-이고 X가 1-메틸벤즈이미다졸-2-일인 화합물.
- 제1항에 있어서, R2가 수소이고, R1이 3급-부틸인 화합물.
- 제1항에 있어서, R2가 수소이고, R1이 헤테로 아릴로서 피리딜, 티에닐, 피라졸릴, 티아졸릴, 티아디아졸릴, 또는 옥사졸릴이고, 이들중 어느 그룹이나 임의로 벤조융합되거나 또는 C1-C4알킬, C1-C4알콕시 또는 할로에 의해 치환될 수 있는 화합물.
- 제7항에 있어서, R1이 피리드-2-일, 티아졸-2-일, 3-메틸-옥사졸-5-일 또는 5-메틸-티아디아졸-2-일인 화합물.
- 제1항에 있어서, 5-(N-3급 부틸카바모일)-4-(2-클로로페닐)-3-에톡시카보닐-6-메틸-2-(2-메틸벤즈이미다졸-1-일)에톡시메틸]-1, 4-디하이드로피리딘, 4-(2-클로로페닐)-3-에톡시카보닐-6-메틸-2-[2-(2-메틸벤즈이미다졸-1-일)에톡시메틸]-5-[N-(피리드-2-일)카바모일]-1, 4-디하이드로피리딘, 4-(2-클로로페닐)-3-에톡시카보닐-6-메틸-2-[2-(2-메틸벤즈이미다졸-1-일)에톡시메틸]-5-[N-(티아졸-2-일)카바모일]-1, 4-디하이드로 피리딘, 5-(N-3급-부틸카바모일)-4-(2-클로로페닐)-3-에톡시카보닐-6-메틸-2-[3-(1-메틸벤즈이미다졸-2-일)프로폭시메틸]-1, 4-디하이드로피리딘, 4-(2-클로로페닐)-3-에톡시카보닐-6-메틸-2-[3-(1-메틸벤즈이미다졸-2-일)프로폭시메틸]-5-[N-(피리드-2-일)카보모일]-1, 4-디하이드로피리딘 또는 5-(N-3급-부틸카바모일)-4-(2-클로페닐)-3-이소프로폭시카보닐-6-메틸-2-[3-(1-메틸벤즈이미다졸-2-일)프로폭시메틸]-1, 4-디하이드로피리딘인 화합물.
- 하기 일반식(Ⅱ)의 화합물, 일반식 RCHO의 화합물 및 일반식(Ⅲ)의 화합물들을 반응시키고, 임의로는 생성물의 약제학적으로 허용되는 염을 형성시킴을 특징으로하여 제1항에 정의된 일반식(I)의 화합물을 제조하는 방법.상기식에서,R, R1, R2, R3, Y및 X는 제1항에 정희한 바와 같다.
- 약제학적으로 허용되는 희석제 또는 담체와 함께 제1항 내지 9항중 어느 한 항에 따른 일반식(I)의 화합물 또는 약제학적으로 허용되는 그의 염으로 이루어진 약제학적 조성물.
- 의약, 용도, 특히 사람에 있어서 알레르기, 염증 및 과분비 상태를 치료하기 위해 사용되는 제1항내지 9항중 어느 한 항에 따른 일반식(I)의 화합물 또는 약제학적으로 허용되는 그의 염.※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB868626698A GB8626698D0 (en) | 1986-11-07 | 1986-11-07 | Therapeutic agents |
GB8626698 | 1986-11-07 | ||
GB8709842 | 1987-04-25 | ||
GB878709842A GB8709842D0 (en) | 1987-04-25 | 1987-04-25 | Therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
KR880006196A true KR880006196A (ko) | 1988-07-22 |
Family
ID=26291518
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR870012409A KR880006196A (ko) | 1986-11-07 | 1987-11-05 | 알레르기 및 염증 치료제인 디하이드로피리딘 |
Country Status (17)
Country | Link |
---|---|
US (1) | US4801598A (ko) |
EP (1) | EP0266989B1 (ko) |
JP (1) | JPH064624B2 (ko) |
KR (1) | KR880006196A (ko) |
CN (1) | CN87107723A (ko) |
AU (1) | AU8089687A (ko) |
DE (1) | DE3763573D1 (ko) |
DK (1) | DK582787A (ko) |
ES (1) | ES2036214T3 (ko) |
FI (1) | FI874866A (ko) |
GR (2) | GR880300183T1 (ko) |
HU (1) | HUT45990A (ko) |
IL (1) | IL84380A0 (ko) |
NO (1) | NO874194L (ko) |
PL (1) | PL268618A1 (ko) |
PT (1) | PT86082B (ko) |
YU (1) | YU201987A (ko) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB8712747D0 (en) * | 1987-05-30 | 1987-07-01 | Pfizer Ltd | Therapeutic agents |
GB8716971D0 (en) * | 1987-07-17 | 1987-08-26 | Pfizer Ltd | Therapeutic agents |
MY104933A (en) | 1987-09-30 | 1994-07-30 | Pfizer Ltd | Platelet activating factor antagonists |
GB8804439D0 (en) * | 1988-02-25 | 1988-03-23 | Pfizer Ltd | Dihydropyridines |
GB8906324D0 (en) * | 1989-03-20 | 1989-05-04 | Pfizer Ltd | 1,4-dihydropyridines |
DE4237617A1 (de) * | 1992-11-06 | 1994-05-11 | Bayer Ag | Verwendung von substituierten Benzimidazolen |
US5496855A (en) * | 1995-01-27 | 1996-03-05 | Smithkline Beecham Corp. | Anti-inflammatory compounds |
AU2002322720B2 (en) | 2001-07-25 | 2008-11-13 | Raptor Pharmaceutical Inc. | Compositions and methods for modulating blood-brain barrier transport |
US6566359B1 (en) | 2002-05-20 | 2003-05-20 | Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College | 2,4,6-trimethyl-1,4-dihydro-pyridine-3,5-dicarboxylic acid esters as neuroprotective drugs |
EP2392258B1 (en) | 2005-04-28 | 2014-10-08 | Proteus Digital Health, Inc. | Pharma-informatics system |
MX2009002893A (es) | 2006-09-18 | 2009-07-10 | Raptor Pharmaceutical Inc | Tratamiento de trastornos hepaticos mediante la administracion de conjugados de la proteina asociada al receptor (rap). |
TR201908314T4 (tr) | 2009-02-20 | 2019-06-21 | 2 Bbb Medicines B V | Glutatyon bazlı ilaç dağıtım sistemi. |
IL295075A (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
US20120077778A1 (en) | 2010-09-29 | 2012-03-29 | Andrea Bourdelais | Ladder-Frame Polyether Conjugates |
JP7148192B1 (ja) | 2022-05-09 | 2022-10-05 | 有限会社Amplus | 表示制御装置および方法並びにプログラム |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0100189B1 (en) * | 1982-07-22 | 1986-05-28 | Pfizer Limited | Dihydropyridine anti-ischaemic and antihypertensive agents |
HUT39179A (en) * | 1984-12-10 | 1986-08-28 | Sandoz Ag | Process for production of derivatives of 1,4-dihydro-piridin |
KR930011486B1 (ko) * | 1985-08-06 | 1993-12-08 | 베링거 만하임 이탈리아 에스.피.에이. | 제약상 유효한 2-티오메틸-치환-1,4-디히드로피리딘 |
EP0225175A3 (en) * | 1985-11-28 | 1988-12-28 | FISONS plc | Dihydropyridine derivatives, processes for their preparation and pharmaceutical compositions thereof |
-
1987
- 1987-10-06 NO NO874194A patent/NO874194L/no unknown
- 1987-10-30 US US07/115,213 patent/US4801598A/en not_active Expired - Fee Related
- 1987-11-02 DE DE8787309674T patent/DE3763573D1/de not_active Expired - Lifetime
- 1987-11-02 EP EP87309674A patent/EP0266989B1/en not_active Expired - Lifetime
- 1987-11-02 ES ES198787309674T patent/ES2036214T3/es not_active Expired - Lifetime
- 1987-11-04 FI FI874866A patent/FI874866A/fi not_active IP Right Cessation
- 1987-11-05 PT PT86082A patent/PT86082B/pt not_active IP Right Cessation
- 1987-11-05 PL PL26861887A patent/PL268618A1/xx unknown
- 1987-11-05 KR KR870012409A patent/KR880006196A/ko not_active Application Discontinuation
- 1987-11-05 IL IL84380A patent/IL84380A0/xx unknown
- 1987-11-06 HU HU874984A patent/HUT45990A/hu unknown
- 1987-11-06 DK DK582787A patent/DK582787A/da not_active Application Discontinuation
- 1987-11-06 AU AU80896/87A patent/AU8089687A/en not_active Abandoned
- 1987-11-06 YU YU02019/87A patent/YU201987A/xx unknown
- 1987-11-06 JP JP62280832A patent/JPH064624B2/ja not_active Expired - Lifetime
- 1987-11-07 CN CN198787107723A patent/CN87107723A/zh active Pending
-
1989
- 1989-06-22 GR GR88300183T patent/GR880300183T1/el unknown
-
1990
- 1990-07-18 GR GR90400486T patent/GR3000820T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
DK582787D0 (da) | 1987-11-06 |
FI874866A (fi) | 1988-05-08 |
NO874194L (no) | 1988-05-09 |
JPS63139167A (ja) | 1988-06-10 |
NO874194D0 (no) | 1987-10-06 |
GR880300183T1 (en) | 1989-06-22 |
US4801598A (en) | 1989-01-31 |
CN87107723A (zh) | 1988-05-18 |
JPH064624B2 (ja) | 1994-01-19 |
EP0266989A3 (en) | 1988-09-28 |
GR3000820T3 (en) | 1991-11-15 |
DK582787A (da) | 1988-05-08 |
HUT45990A (en) | 1988-09-28 |
FI874866A0 (fi) | 1987-11-04 |
DE3763573D1 (de) | 1990-08-09 |
YU201987A (en) | 1988-12-31 |
ES2036214T3 (es) | 1993-05-16 |
EP0266989A2 (en) | 1988-05-11 |
IL84380A0 (en) | 1988-04-29 |
PL268618A1 (en) | 1988-09-01 |
PT86082B (pt) | 1990-11-20 |
PT86082A (en) | 1987-12-01 |
AU8089687A (en) | 1988-05-12 |
EP0266989B1 (en) | 1990-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR880006196A (ko) | 알레르기 및 염증 치료제인 디하이드로피리딘 | |
US4466972A (en) | Benzoxadiazoles and benzothiadiazoles, their preparation and pharmaceutical compositions containing them | |
KR950704304A (ko) | 이환식 헤테로환 함유 술폰아미드 및 술폰산 에스테르 유도체(bicyclic heterocyclic sulfonamide and sulfonic ester derivatives) | |
KR910004580A (ko) | 신규 화합물 | |
DE69331010D1 (de) | Benzoxazol- und benzothiazol-derivate als arzneimittel | |
EA200401381A1 (ru) | 3-гетероарилзамещённые изоксазолины | |
LU90711I2 (fr) | 5-(4-/2-(N-m-thyl-n-(2-pyridyl)amino)-thoxy/benzyl)-2,4-thiazolidinedione ou ses sels et d-riv-s pharmaceutiquement acceptables en particulier son sel mal-ate ou ses solvates pharmaceutiquement acceptables | |
DE69016899T2 (de) | Thiazolidinedionederivate. | |
RU2002125860A (ru) | Новые производные циклического амида | |
KR880002829A (ko) | 디하이드로피리딘 항알러지제 및 소염제 | |
FI882081A0 (fi) | 2-substituerade e-fusionerade (1,2,4) triazolo(1,5-c) pyrimidiner, farmaceutiska kompositioner och deras anvaendning. | |
KR900004693A (ko) | 피리딘 화합물 및 그의 약제학적 용도 | |
KR930004262A (ko) | 메타노안트라센 화합물 | |
KR880013920A (ko) | 디하이드로피리딘 화합물 및 이의 제조방법 | |
KR890008078A (ko) | 치환 알킬 아민 유도체 | |
KR890009921A (ko) | 4- 헤테로펜타시클릭-4-(n-(페닐)아미도)피페리딘 유도체, 제약학적 조성물 및 이런 화합물을 사용하는 방법 | |
KR960001202B1 (ko) | 일차 복소환 아민의 디셀레노비스 벤조산 아미드와 그 제조방법 | |
US3826791A (en) | Heterocyclic amides of 4-hydroxy-2h-1-benzothiopyran-3-carboxylic acid 1,1-dioxide and process for their production | |
DE69117879D1 (de) | Arzneimittel für die Verhütung und Behandlung von Krankheiten der Kreislauforgane enthaltend Spiro-3-heteroazolidin-Verbindungen | |
KR920000758A (ko) | 항-알레르기 활성을 갖는 티아졸리딘 카르복실 산 아미드 유도체, 그의 제조방법 및 용도 | |
KR900016201A (ko) | 디아진 유도체와 그 제조방법 및 이를 함유하는 약제 | |
DK158979C (da) | Aminopropanol-derivater af substituerede 2-hydroxypropiophenoner og terapeutiske praeparater med indhold deraf | |
NZ535476A (en) | 4-(diarylmethyl)-1-piperazinyl derivatives | |
KR910004614A (ko) | 벤조티아진 유도체, 그의 제조방법 및 의약품 또는 의약품을 합성하기위한 중간물질로의 응용 | |
JPS59167586A (ja) | チオフエン誘導体 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |